Literature DB >> 25483541

Characteristics of pertussis outbreaks in Catalonia, Spain, 1997 to 2010.

Inma Crespo1, Sonia Broner, Núria Soldevila, Ana Martínez, Pere Godoy, Maria-Rosa Sala-Farré, Maria Company, Cristina Rius, Angela Domínguez, The Pertussis Working Group Of Catalonia.   

Abstract

In Catalonia, pertussis outbreaks must be reported to the Department of Health. This study analyzed pertussis outbreaks between 1997 and 2010 in general and according to the characteristics of the index cases. The outbreak rate, hospitalization rate and incidence of associated cases and their 95%CI were calculated. Index cases were classified in two groups according to age (<15 years and ≥15 years) and the vaccine type received: whole cell vaccine (DTwP) or acellular vaccine (DTaP). During the study period, 230 outbreaks were reported. The outbreak rate was 2.43 × 10(-6) persons-year, and outbreaks ranged from 2 to 32 cases, with a median duration of 18 days. There were 771 associated cases, with an incidence rate of 0.8 × 10(-5) persons-year.   After classifying outbreaks according to the age of the index case, 126 outbreaks (1.3 × 10(-6) persons-year) had an index case aged <15 y and 87 (0.87 × 10(-6) person-year) had an index case aged ≥15 y (RR = 1.44, 95%CI 1.10-1.90; P = 0.007). Between 2003 and 2010, after the introduction of the acellular vaccine, the index case was vaccinated with DTwP vaccine in 25 outbreaks (0.43 × 10(-6) persons-year) and with DTaP vaccine in 32 outbreaks (0.55 × 10(-6) person-year) (RR = 0.78, 95%CI 0.46-1.31; P = 0.35). Of cases, 37.2% were correctly vaccinated, suggesting waning immunity of pertussis vaccine protection and endogenous circulation of pertussis. A greater number of outbreaks had an index case aged <15 y. No changes in the disease incidence, associated cases and hospitalization rate were observed after the introduction of DTaP.

Entities:  

Keywords:  acellular pertussis vaccine; hospitalization; pertussis; surveillance; whole cell pertussis vaccine

Mesh:

Substances:

Year:  2014        PMID: 25483541      PMCID: PMC4514391          DOI: 10.4161/hv.36156

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  26 in total

1.  Pertussis outbreaks and pertussis vaccines: new insights, new concerns, new recommendations?

Authors:  Gregory A Poland
Journal:  Vaccine       Date:  2012-11-19       Impact factor: 3.641

2.  Pertussis is still common in a highly vaccinated infant population.

Authors:  Elettra Berti; Elena Chiappini; Elisa Orlandini; Luisa Galli; Maurizio de Martino
Journal:  Acta Paediatr       Date:  2014-04-29       Impact factor: 2.299

3.  Review of the 2008-2009 pertussis epidemic in NSW: notifications and hospitalisations.

Authors:  Paula J Spokes; Helen E Quinn; Jeremy M McAnulty
Journal:  N S W Public Health Bull       Date:  2010 Jul-Aug

4.  Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance.

Authors:  Lennart Nilsson; Tiia Lepp; Kerstin von Segebaden; Hans Hallander; Lennart Gustafsson
Journal:  Vaccine       Date:  2011-11-15       Impact factor: 3.641

5.  Pertussis before and after the introduction of acellular pertussis vaccines in Finland.

Authors:  Annika Elomaa; Qiushui He; Nhu Nguyen Tran Minh; Jussi Mertsola
Journal:  Vaccine       Date:  2009-07-21       Impact factor: 3.641

6.  Clinical definitions of pertussis: Summary of a Global Pertussis Initiative roundtable meeting, February 2011.

Authors:  James D Cherry; Tina Tan; Carl-Heinz Wirsing von König; Kevin D Forsyth; Usa Thisyakorn; David Greenberg; David Johnson; Colin Marchant; Stanley Plotkin
Journal:  Clin Infect Dis       Date:  2012-03-19       Impact factor: 9.079

7.  Global population structure and evolution of Bordetella pertussis and their relationship with vaccination.

Authors:  Marieke J Bart; Simon R Harris; Abdolreza Advani; Yoshichika Arakawa; Daniela Bottero; Valérie Bouchez; Pamela K Cassiday; Chuen-Sheue Chiang; Tine Dalby; Norman K Fry; María Emilia Gaillard; Marjolein van Gent; Nicole Guiso; Hans O Hallander; Eric T Harvill; Qiushui He; Han G J van der Heide; Kees Heuvelman; Daniela F Hozbor; Kazunari Kamachi; Gennady I Karataev; Ruiting Lan; Anna Lutyńska; Ram P Maharjan; Jussi Mertsola; Tatsuo Miyamura; Sophie Octavia; Andrew Preston; Michael A Quail; Vitali Sintchenko; Paola Stefanelli; M Lucia Tondella; Raymond S W Tsang; Yinghua Xu; Shu-Man Yao; Shumin Zhang; Julian Parkhill; Frits R Mooi
Journal:  mBio       Date:  2014-04-22       Impact factor: 7.867

8.  Bordetella pertussis in sporadic and outbreak settings in Alberta, Canada, July 2004-December 2012.

Authors:  Sumana Fathima; Christina Ferrato; Bonita E Lee; Kimberley Simmonds; Lin Yan; Shamir N Mukhi; Vincent Li; Linda Chui; Steven J Drews
Journal:  BMC Infect Dis       Date:  2014-01-30       Impact factor: 3.090

9.  Report of a pertussis outbreak in a low coverage booster vaccination group of otherwise healthy children in Italy.

Authors:  Silvio Tafuri; Maria Serena Gallone; Domenico Martinelli; Rosa Prato; Maria Chironna; Cinzia Germinario
Journal:  BMC Infect Dis       Date:  2013-11-14       Impact factor: 3.090

10.  Pertussis in the central-west region of Brazil: one decade study.

Authors:  Angelita Fernandes Druzian; Yvone Maia Brustoloni; Sandra Maria do Valle Leone Oliveira; Vanessa Terezinha Gubert de Matos; Adriana Carla Garcia Negri; Clarice Souza Pinto; Silvia Asato; Cirlene dos Santos Gonçalves Urias; Anamaria Mello Miranda Paniago
Journal:  Braz J Infect Dis       Date:  2013-11-22       Impact factor: 3.257

View more
  4 in total

1.  Pertussis in early life: underdiagnosed, severe, and risky disease. A seven-year experience in a pediatric tertiary-care hospital.

Authors:  Chiara Di Camillo; Anna Chiara Vittucci; Livia Antilici; Claudia Ciarlitto; Giulia Linardos; Carlo Concato; Laura Lancella; Alberto Villani
Journal:  Hum Vaccin Immunother       Date:  2020-08-05       Impact factor: 3.452

Review 2.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

3.  Direct Medical Costs of Four Vaccine-Preventable Infectious Diseases in Older Adults in Spain.

Authors:  Ángel Gil de Miguel; José María Eiros Bouza; Luis Ignacio Martínez Alcorta; Daniel Callejo; Carlos Miñarro; Laura Amanda Vallejo-Aparicio; Andrea García; Mónica Tafalla; María Del Rosario Cambronero; Rubén Rodríguez; Laura Martin-Gomez
Journal:  Pharmacoecon Open       Date:  2022-03-07

4.  Genomic Sequencing of Bordetella pertussis for Epidemiology and Global Surveillance of Whooping Cough.

Authors:  Valérie Bouchez; Julien Guglielmini; Mélody Dazas; Annie Landier; Julie Toubiana; Sophie Guillot; Alexis Criscuolo; Sylvain Brisse
Journal:  Emerg Infect Dis       Date:  2018-06       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.